Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online October 31, 2007
Diabetes 57:244-254, 2008
DOI: 10.2337/db07-0615
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0615v1
57/1/244    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaxillaire, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaxillaire, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study

Martine Vaxillaire1, Jacques Veslot1, Christian Dina1, Christine Proença1, Stéphane Cauchi1, Guillaume Charpentier2, Jean Tichet3, Frédéric Fumeron4,5, Michel Marre4,5,6, David Meyre1, Beverley Balkau7,8, Philippe Froguel1,9 for the DESIR Study Group

1 UMR8090 and Institute of Biology, Lille 2 University, CNRS and Pasteur Institute, Lille, France
2 Department of Endocrinology-Diabetology, Centre Hospitalier Sud-Francilien, Corbeil-Essonnes, France
3 Regional Institute for Health, Tours, France
4 INSERM U695, Paris, Francem
5 Université Paris Diderot, Paris, France
6 Department of Endocrinology-Diabetology and Nutrition, Bichat Claude Bernard Hospital, Paris, France
7 INSERM U780-IFR69, Villejuif, France
8 University of Paris-Sud, Villejuif, France
9 Department of Genomic Medicine, Hammersmith Hospital, Imperial College London, London, U.K

Address correspondence and reprint requests to Dr. Martine Vaxillaire, CNRS UMR8090, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, 59019 Lille, France. E-mail: martine.vaxillaire{at}good.ibl.fr

Key Words: AUC, area under the curve • DESIR, Data from an Epidemiological Study on the Insulin Resistance syndrome • FPG, fasting plasma glucose • HOMA, homeostasis model assessment • HOMA-B, HOMA of β-cell function • HOMA-IR, HOMA of insulin resistance • IFG, impaired fasting glycemia • IL, interleukin • MAF, minor allele frequency • ROC, receiver operating characteristic • SNP, single nucleotide polymorphism

OBJECTIVE— The emerging picture of type 2 diabetes genetics involves differently assembled gene variants, each modestly increasing risk with environmental exposure. However, the relevance of these genes for disease prediction has not been extensively tested.

RESEARCH DESIGN AND METHODS— We analyzed 19 common polymorphisms of 14 known candidate genes for their contribution to prevalence and incidence of glucose intolerance in the DESIR (Data from an Epidemiological Study on the Insulin Resistance syndrome) prospective study of middle-aged Caucasian subjects, including 3,877 participants (16.8% with hyperglycemia and 7.9% with diabetes after the 9-year study).

RESULTS— The GCK (Glucokinase) –30A allele was associated with increased type 2 diabetes risk at the end of the follow-up study (adjusted OR 1.34 [95% CI 1.07–1.69]) under an additive model, as supported in independent French diabetic case subjects (OR 1.22, P = 0.007), with increased fasting glycemia (0.85% per A allele, P = 6 x 10–5) and decreased homeostasis model assessment of β-cell function (4%, P = 0.0009). IL6 (Interleukin- 6) –174 G/C interacts with age in disease risk and modulates fasting glycemia according to age (1.36% decrease over 56 years, P = 5 x 10–5). These polymorphisms together with KCNJ11 (Kir6.2)-E23K and TCF7L2-rs7903146 may predict diabetes incidence in the DESIR cohort. Each additional risk allele at GCK, TCF7L2, and IL6 increased risk by 1.34 (P = 2 x 10–6), with an OR of 2.48 (95% CI 1.59–3.86), in carriers of at least four at-risk alleles compared with those with none or one risk allele.

CONCLUSIONS— Our data confirm several at-risk polymorphisms for type 2 diabetes in a general population and demonstrate that prospective studies are valuable designs to complement classical genetic approaches.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.